Sanofi

Sanofi Pays to Exit Regeneron Pact

Sanofi Invests €80 Million in BioNTech

Sanofi to Slash Jobs In France

Sanofi and Denali Target MS and ALS

Sanofi May Move Rare Disease to Boston Area

Sanofi Completes Divestiture of European Generics Business, Renames Active Ingredient Solutions Business

Bayer and Sanofi “swap” Executives

European Drugmakers Deal with Misconduct

EMA cuts Activities on Higher Staff Losses

Sanofi Agrees to sell Generics to Advent

Sanofi and Advent in Talks Over Generics

Along the Acquisition Trail

Sanofi Plans €350m Vaccine Plant in Canada

Evotec and Sanofi to Link on Infectious Diseases

Sanofi Wins Antitrust Clearances for Ablynx

Philippines Finds Link Between Vaccine and Deaths

Sanofi to Buy Ablynx for nearly €4 billion

Sanofi to Buy Hemophilia Specialist Bioverativ

Sanofi to Refund Philippines for Dengvaxia

2017 Through the Rear-view Mirror

2017 Through the Rear-view Mirror

2017 Through the Rear-view Mirror

2017 Through the Rear-view Mirror

Teva Realigns, may Slash 25% of Workforce

The German Capital Region

The German capital region is one of the leading life sciences and healthcare industries centers in the world. A total of around 30,000 employees work in more than 500 companies in the pharma, the biotech and the medtech industry.

Sanofi, Principia to Develop MS Candidate

Sanofi Charges Mylan With Lantus Breach

Pfizer to Launch Consumer Health Sale Soon?

Lonza Buys Shire US Site

Sanofi Completes Protein Sciences Buy

Merck KGaA May Sell Consumer Health

Mylan Finalizes US EpiPen Settlement

Sanofi Sues US Merck over Insulin Drug

Sanofi and Ablynx Link on Nanobody Therapeutics

Sanofi to Acquire Protein Sciences in US